CHARMAINE JAN GONZALVO: Open Payments
NPI 1457059537 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 27 payments from 17 companies in 2025. Trend: 2023 $399 · 2024 $856 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $140 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Echosens North America, Inc. | 2 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
Products named: General - Pain Management, TRELEGY ELLIPTA, REXULTI, LINZESS, GARDASIL 9, Fibroscan, JARDIANCE, MOUNJARO.
Industry payments across HI — which companies pay providers there.
